Evaluation of the Effect of Different Doses of Ozone Therapy on Pain and Function of Patients With Knee Osteoarthritis
1 other identifier
interventional
60
1 country
1
Brief Summary
This study is designed as a randomized clinical trial that will be conducted in Hazrat Rasool Akram Hospital in Tehran. Patients with knee osteoarthritis were selected based on the study entry criteria and written consent was obtained from them. Then, by random assignment, patients will be divided into three treatment groups: control group (under oxygen gas injection), intervention group 1 (intra-articular injection of ozone with a dose of 20 micrograms) and intervention group 2 (intra-articular injection of ozone with a dose of 40 micrograms).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Nov 2023
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 28, 2023
CompletedFirst Posted
Study publicly available on registry
October 18, 2023
CompletedStudy Start
First participant enrolled
November 20, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 10, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2024
CompletedJuly 16, 2024
July 1, 2024
5 months
September 28, 2023
July 13, 2024
Conditions
Outcome Measures
Primary Outcomes (2)
Questionnaire evaluations womac
Western Ontario and McMaster Universities Osteoarthritis Index questionnaire or WOMAC for short: This questionnaire has 24 items which are arranged in three sections. 1. The first part examines pain with five items in different positions of walking, climbing stairs, while resting in bed, while sitting or sleeping, and standing. 2. The second part examines morning dryness and joint stiffness at the end of the day with two items. 3. The third section examines the patient's functional activities in different situations with seventeen items. It is worth mentioning that the translation, localization and validation of WOMAC questionnaire in Iran was done in 2014 by Dr. Ebrahimzadeh and his colleagues.
before the intervention and two weeks later, one month and three months after the intervention
Visual Analogue Scale
Feeling pain in the knee with vas criteria
before the intervention and two weeks later, one month and three months after the intervention
Secondary Outcomes (3)
range of motion
before the intervention and two weeks later, one month and three months after the intervention
Timed Up & Go functional test
before the intervention and two weeks later, one month and three months after the intervention
Six-Minute Walk Functional Test
before the intervention and two weeks later, one month and three months after the intervention
Study Arms (3)
Intervention group 1 (O3 20mg)
EXPERIMENTALthe patient is lying on the bed with his knee flexed at about 45 degrees. Then The syringe containing ozone is prepared by a sports medicine assistant and covered with a label so that the clinician is not aware of the injected ozone dose. Lateral Approach will be used for intra-articular injection. after preparation and drape of the desired position and aspiration, the ozone composition will be injected into the joint. In order to inject for this group, a 10 cc needle and a predetermined concentration of 20 micrograms is injected under sterile conditions. The duration of the injection will be 15-20 seconds. The number of sessions considered for injection will be three sessions, once a week for three weeks. The second and third injection will be done under the same conditions as the first session. In this study, Ozonette Sedecal device ( Spain) will be used. And the exercise therapy protocol is performed.
Intervention group 2 (O3 40mg)
ACTIVE COMPARATORJust like intervention group 1, in this group, a predetermined concentration of 40 micrograms ozone is injected under sterile conditions.According to the standard treatment guidelines of the American College of Rheumatology, 1gram of acetaminophen in two doses of 500 mg is allowed up to two weeks after daily injections, which is applicable to all three groups.
Control group
PLACEBO COMPARATORJust like intervention group 1, in this group, a syringe containing oxygen without ozone is injected under sterile conditions.
Interventions
the patient is lying on the bed with his knee flexed at about 45 degrees. Then The syringe containing ozone is prepared by a sports medicine assistant and covered with a label so that the clinician is not aware of the injected ozone dose. Lateral Approach will be used for intra-articular injection. after preparation and drape of the desired position and aspiration, the ozone composition will be injected into the joint. In order to inject for this group, a 10 cc needle and a predetermined concentration of 20 and 40 micrograms ozone are used under sterile conditions. The duration of the injection will be 15-20 seconds. The number of sessions considered for injection will be three sessions, once a week for three weeks. The second and third injection will be done under the same conditions as the first session. In this study, Ozonette Sedecal device ( Spain) will be used. And the exercise therapy protocol is performed.
Eligibility Criteria
You may qualify if:
- Having primary knee osteoarthritis grade 2 and 3 according to the doctor's diagnosis and based on the Kellgren and Lawrence criteria (the presence of knee pain, morning dryness for less than 30 minutes, crypts during movement and radiological signs of osteoarthritis including joint space reduction, subchondral bone sclerosis and osteophyte formation in knee)
- Age 50-75 years
- Suffering from continuous knee pain for at least six months and with a severity of at least 4 based on the VAS criteria in physical activities such as going up and down the stairs, sitting for a long time and squatting
- Ability to walk independently for at least 30 meters
- Body mass index equal to or less than 35
- Complete consent of the patient to participate in the research
- Balanced mental state
You may not qualify if:
- History of intra-articular injections in the knee during the last six months
- Suffering from neuromuscular diseases
- Presence of acute traumatic injury in other ligaments and structures of the knee joint as confirmed by a specialist doctor
- History of previous surgery or injury in the knee and other joints of the lower limbs during the last year
- Presence of bone implants
- The presence of new fractures in the lower limbs during the last year
- Getting malignant tumors
- Participation in sports therapy and physiotherapy programs during the last three months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Ahmad Nazarilead
Study Sites (1)
Department of Sports and Exercise Medicine, School of Medicine, Iran University of Medical Sciences
Tehran, 14496-14535, Iran
Related Publications (1)
Arjmanddoust Z, Nazari A, Moezy A. Efficacy of two doses of intra-articular ozone therapy for pain and functional mobility in knee osteoarthritis: a double-blind randomized trial. Adv Rheumatol. 2025 Mar 6;65(1):11. doi: 10.1186/s42358-025-00443-w.
PMID: 40050950DERIVED
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- Clinician: injection interventions are performed under the supervision of a sports medicine specialist who does not know the dose of the injections and only injects the solution prepared by another assistant. Assessor Clinician: Assessments before and after interventions will be done by a sports medicine resident who is not involved in running the trial. Statistical analyzer: The analysis of the research data will be done by a statistical consultant who is not aware of the patient groups.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
September 28, 2023
First Posted
October 18, 2023
Study Start
November 20, 2023
Primary Completion
April 10, 2024
Study Completion
May 1, 2024
Last Updated
July 16, 2024
Record last verified: 2024-07